Cell and Gene Therapy Bio-manufacturing Market Exclusive Report on the Latest Revenue and Future Scope

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Bio-manufacturing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Equipment, And Software Solutions), Usage (Commercial-Stage Manufacturing And Research-Stage Manufacturing), Application (Upstream Processing, Harvesting, And Downstream Processing), And End-User (Life Science Companies, Contract Research Organizations (Cros), Contract Manufacturing Organizations (CMOs), And Cell Banks)- Market Outlook And Industry Analysis 2034"

The global cell and gene therapy bio-manufacturing market is estimated to reach over USD 40.2 billion by 2034, exhibiting a CAGR of 11.4% during the forecast period.

Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1692

The global cell and gene therapy biomanufacturing market is poised for robust growth, driven by the increasing number of approved therapies and the escalating demand for advanced infrastructure. The expanding range of therapeutic indications for cell and gene therapies has further accelerated the need for large-scale manufacturing capabilities. This growth is supported by substantial investments from government entities and leading industry stakeholders.

Over the past decade, approximately USD 2.3 billion has been invested in gene therapy companies, reflecting strong interest from major pharmaceutical and biotechnology firms in this sector. Contract Development and Manufacturing Organizations (CDMOs), Contract Manufacturing Organizations (CMOs), and in-house manufacturers are increasingly viewing cell and gene therapy as a strategic area for capital allocation and expansion. Moreover, ongoing research and development activities in this field continue to receive significant funding from biopharmaceutical companies.

List of Prominent Players in the Cell and Gene Therapy Bio-manufacturing Market:
• Becton, Dickinson and Company
• Endress+Hauser Group Services AG (Analytik Jena GmbH)
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• General Electric Company (G.E. Healthcare)
• Getinge AB
• Infors AG
• Lonza Group Ltd
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• PIERRE GUERIN
• Sartorius AG (Sartorius Stedim Biotech S.A.)
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Market Dynamics:
Drivers-
The global cell and gene therapy biomanufacturing market is experiencing significant growth, primarily driven by the increasing prevalence of cancer and other target diseases. According to the International Agency for Research on Cancer (IARC), there were an estimated 19.3 million new cancer cases worldwide in 2020, highlighting the escalating demand for advanced therapeutic solutions. Similarly, a comprehensive systematic review published in the Journal of Orthopaedic Surgery and Research reported a global osteoporosis prevalence of 18.3%, indicating a substantial patient population that could benefit from innovative treatments such as stem cell therapy.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1692

Challenges:
Despite the promising growth, the market faces significant challenges, notably the high costs associated with advanced therapies. For instance, the U.S. Food and Drug Administration (FDA) approved the chimeric antigen receptor T-cell (CAR-T) therapy, tisagenlecleucel, for treating certain types of leukemia, with a single infusion priced at approximately USD 475,000.

Regional Trends:
North America is anticipated to hold a substantial share of the cell and gene therapy biomanufacturing market, driven by a well-established healthcare infrastructure and a growing elderly population susceptible to various diseases. The United States, in particular, is witnessing increased utilization of gene therapies across diagnostic, therapeutic, and drug development applications, especially in oncology. This trend is expected to continue, given the rising patient population and the country's commitment to advancing medical research and innovation.

Recent Developments:
• In January 2022, AllogeneTherapeutics Inc and AntionBiosciences Inc. formed an exclusive collaboration and global license agreement for Antion's miRNA technology (miCAR) to advance multiplex gene silencing as an additional tool in the development of next-generation allogeneic CAR T products.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1692

Segmentation of Cell and Gene Therapy Bio-manufacturing Market-
By Product Type-
• Consumables
o Culture Supplements
 Media
 Serum
 Macronutrients
o Single-Use Liquids
o Cell Culture Reagents
o Cell Quantification Kits
• Equipment
o Bioreactors/Fermenters
 Continuous Bioreactors
 Single-Use Bioreactors
o Mixing Systems
o Cell Counters
o Cell Sorters
o Centrifuges
o Incubators
o Biosafety Cabinets
o Freezers
o PCR Systems
o Transfection Systems
o Storage Tanks
o Others
• Software Solutions
By Usage-
• Commercial Stage Manufacturing
• Research Stage Manufacturing
By Application-
• Upstream Processing
o Formulation and Hydration
o Cell Culture Processing
• Harvesting
• Downstream Processing
o Separation and Filtration
o Fill and Finish Operations
By End-User-
• Life Science Companies
o Equipment
o Consumables
o Software Solutions
• Contract Research Organizations (CROs)
o Equipment
o Consumables
o Software Solutions
• Contract Manufacturing Organizations (CMOs)
o Equipment
o Consumables
o Software Solutions
• Cell Banks
o Equipment
o Consumables
o Software Solutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Get more information: @
https://www.insightaceanalytic.com/report/cell-and-gene-therapy-bio-manufacturing-market/1692

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.